Werbung
Werbung

NXTC

NXTC logo

NextCure, Inc. Common Stock

13.38
USD
Gesponsert
-0.21
-1.51%
09. Jan., 15:56 UTC -5
Geschlossen
exchange

Nach-Markt

13.37

-0.02
-0.11%

NXTC Ergebnisberichte

Positives Überraschungsverhältnis

NXTC übertreffen die 12 der letzten 27Schätzungen.

44%

Nächster Bericht

Datum des nächsten Berichts
04. März 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/
-$2.46
Implizierte Änderung von Q3 25 (Revenue/ EPS)
--
/
-23.60%
Implizierte Änderung von Q4 24 (Revenue/ EPS)
--
/
-50.00%

NextCure, Inc. Common Stock earnings per share and revenue

On 05. Nov. 2025, NXTC reported earnings of -3.22 USD per share (EPS) for Q3 25, beating the estimate of -4.06 USD, resulting in a 20.75% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +1.97% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 5 analysts forecast an EPS of -2.46 USD, with revenue projected to reach -- USD, implying an decrease of -23.60% EPS, and increase of 0.00% in Revenue from the last quarter.
FAQ
For Q3 2025, NextCure, Inc. Common Stock reported EPS of -$3.22, beating estimates by 20.75%, and revenue of $0.00, 0% as expectations.
The stock price moved up 1.97%, changed from $9.63 before the earnings release to $9.82 the day after.
The next earning report is scheduled for 04. März 2026.
Based on 5 analysts, NextCure, Inc. Common Stock is expected to report EPS of -$2.46 and revenue of -- for Q4 2025.
Scheck FXEmpire's Earnings Calendar for today's list of reporting companies.
Werbung